R. Van Ginckel

480 total citations
23 papers, 418 citations indexed

About

R. Van Ginckel is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, R. Van Ginckel has authored 23 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Genetics and 6 papers in Oncology. Recurrent topics in R. Van Ginckel's work include Estrogen and related hormone effects (9 papers), Retinoids in leukemia and cellular processes (6 papers) and Cancer Treatment and Pharmacology (4 papers). R. Van Ginckel is often cited by papers focused on Estrogen and related hormone effects (9 papers), Retinoids in leukemia and cellular processes (6 papers) and Cancer Treatment and Pharmacology (4 papers). R. Van Ginckel collaborates with scholars based in Belgium, Netherlands and Germany. R. Van Ginckel's co-authors include R. De Coster, Walter Wouters, C R Bowden, Paul A. J. Janssen, M. De Brabander, M C Coene, Carl Van Hove, Luc Wouters, D End and J. Bruynseels and has published in prestigious journals such as Annals of the New York Academy of Sciences, The Journal of Urology and British Journal of Cancer.

In The Last Decade

R. Van Ginckel

23 papers receiving 397 citations

Peers

R. Van Ginckel

GENET

ONCOL

J. Bruynseels Belgium

Bas‐jan M. van der Leede Netherlands

Juan José Mandoki Mexico

Eddy Freyne Belgium

Christa Gerth Germany

B.‐L. Nguyen France

Mary Szatkowski Ozers United States

Anne M. McCormick United States

Anne‐Marie Gaben France

Francis Fouchier France

J. Bruynseels Belgium

R. Van Ginckel

186 ×0.9

GENET

137 ×0.7

31 ×0.5

57 ×1.0

ONCOL

52 ×1.0

Citations per year, relative to R. Van Ginckel R. Van Ginckel (= 1×) peers J. Bruynseels

Countries citing papers authored by R. Van Ginckel

Since Specialization

Citations

This map shows the geographic impact of R. Van Ginckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Van Ginckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Van Ginckel more than expected).

Fields of papers citing papers by R. Van Ginckel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Van Ginckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Van Ginckel. The network helps show where R. Van Ginckel may publish in the future.

Co-authorship network of co-authors of R. Van Ginckel

This figure shows the co-authorship network connecting the top 25 collaborators of R. Van Ginckel. A scholar is included among the top collaborators of R. Van Ginckel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Van Ginckel. R. Van Ginckel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ginckel, R. Van, Bieneke Janssen, Wim Floren, et al.. (2002). Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity. British Journal of Cancer. 86(4). 605–611. 75 indexed citations

Ginckel, R. Van, et al.. (1996). Effects of combined and sequential treatment with tamoxifen and the aromatase inhibitor vorozole on 7,12-dimethylbenz(a) anthracene-induced mammary carcinoma in the rat. Cancer Chemotherapy and Pharmacology. 38(1). 21–28. 14 indexed citations

Ginckel, R. Van, et al.. (1996). Analysis of the oxidative catabolism of retinoic acid in rat Dunning R3327G prostate tumors. The Prostate. 29(1). 36–41. 8 indexed citations

Ginckel, R. Van, et al.. (1996). Analysis of the oxidative catabolism of retinoic acid in rat Dunning R3327G prostate tumors. The Prostate. 29(1). 36–41. 4 indexed citations

Smets, G., R. Van Ginckel, G. Daneels, et al.. (1995). Liarozole, an antitumor drug, modulates cytokeratin expression in the dunning AT‐6sq prostatic carcinoma through in situ accumulation of all‐trans‐retinoic acid. The Prostate. 27(3). 129–140. 20 indexed citations

Moorselaar, R. Jeroen A. van, R. Van Ginckel, Luc Wouters, et al.. (1994). Antitumoral Effects of Liarozole in Androgen-Dependent and Independent R3327-Dunning Prostate Adenocarcinomas. The Journal of Urology. 151(1). 217–222. 34 indexed citations

Belle, S.J.P. Van, et al.. (1994). Phase I trial of erbulozole (R55104).. PubMed. 13(6B). 2389–91. 4 indexed citations

Wouters, Walter, et al.. (1993). Pharmacology of vorozole. The Journal of Steroid Biochemistry and Molecular Biology. 44(4-6). 617–621. 23 indexed citations

Wouters, Walter, et al.. (1992). Aromatase inhibition by R 83 842, the dextro isomer of R 76 713, in JEG-3 choriocarcinoma grown in ovariectomized nude mice. The Journal of Steroid Biochemistry and Molecular Biology. 41(3-8). 761–764. 6 indexed citations

10.

Coster, R. De, Walter Wouters, R. Van Ginckel, et al.. (1992). Experimental studies with liarozole (R 75 251): An antitumoral agent which inhibits retinoic acid breakdown. The Journal of Steroid Biochemistry and Molecular Biology. 43(1-3). 197–201. 41 indexed citations

11.

Ginckel, R. Van, et al.. (1992). Levamisole plus 5-fluorouracil inhibits the growth of human colorectal xenografts in nude mice. European Journal of Cancer. 28(6-7). 1137–1139. 5 indexed citations

12.

Wouters, Walter, et al.. (1991). Aromatase in the human choriocarcinoma JEG-3: Inhibition by R 76 713 in cultured cells and in tumors grown in nude mice. The Journal of Steroid Biochemistry and Molecular Biology. 38(4). 415–422. 27 indexed citations

13.

Coster, R. De, Walter Wouters, C R Bowden, et al.. (1990). New non-steroidal aromatase inhibitors: Focus on R76713. The Journal of Steroid Biochemistry and Molecular Biology. 37(3). 335–341. 49 indexed citations

14.

Coster, R. De, et al.. (1990). Endocrine and Antitumoral Effects of R76713 in Rats. Journal of enzyme inhibition. 4(2). 159–167. 10 indexed citations

15.

Ginckel, R. Van, et al.. (1990). Antitumoral effects of R 75251 on the growth of transplantable R3327 prostatic adenocarcinoma in rats. The Prostate. 16(4). 313–323. 26 indexed citations

16.

Brabander, B. De, et al.. (1989). The protective effect of behavioral activation on the growth of a syngeneic tumor and mortality in socially stressed mice. The European Journal of Psychiatry. 3(4). 238–244. 1 indexed citations

17.

Ginckel, R. Van, et al.. (1989). Influence of the synthetic microtubule inhibitor erbulozole (P.I.N.N.) (R 55 104), a new tubulozole congener, and gamma irradiation on murine tumors in vivo. European Journal of Cancer and Clinical Oncology. 25(10). 1499–1504. 3 indexed citations

18.

Ginckel, R. Van, Rudy Willebrords, Marc De Brabander, et al.. (1989). Interaction between the microtubule inhibitor tubulozole and gamma-irradiation in murine tumors in vivo. International Journal of Radiation Oncology*Biology*Physics. 16(1). 177–182. 2 indexed citations

19.

Ginckel, R. Van, et al.. (1987). Numerical evaluation of the kidney invasion test.. PubMed. 7(4). 230–41. 7 indexed citations

20.

Brabander, M. De, et al.. (1978). Dl-2-oxo-3-(2-mercaptoethyl)-5-phenylimidazolidine. A sulfhydryl metabolite of levamisole that interacts with microtubules. Chemico-Biological Interactions. 23(1). 45–63. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact